Key Capital Management
GSK icon

Key Capital Management’s GSK GSK Stock Holding History

Key Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$241K Buy
4,959
+4,547
+1,104% +$232K 0.09% 126
2026
Q2 		$21.6K Sell
412
-548
-57% -$29K 0.01% 243
2026
Q1 		$53K Buy
960
+653
+213% +$35.4K 0.04% 146
2025
Q4 		$15.1K Buy
+307
New +$14.3K 0.01% 239

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Key Capital Management's GSK Position: Q3 2026 in Review

Key Capital Management increased its GSK (GSK) stake by 1,104% in Q3 2026, buying an estimated $232K and bringing the position to 4,959 shares worth $241K. The position accounts for 0.09% of the portfolio, ranked #126.

Key Capital Management first reported a position in GSK in Q4 2025 and has held it in 4 quarters since. 654 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Key Capital Management held 4,959 shares of GSK worth $241K as of Q3 2026.
  • Key Capital Management bought 4,547 GSK shares in Q3 2026, an estimated $232K.
  • GSK made up 0.09% of Key Capital Management's portfolio in Q3 2026, its #126 holding.
  • Key Capital Management first reported a position in GSK in Q4 2025 and has held it in 4 quarters since.
  • 654 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Key Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.